Clinica Gaias Santiago
- Address
- lock Available on a paid plan
Clinica Gaias Santiago - Autoimmune and Inflammatory Disease Research Center
Clinica Gaias Santiago is a specialized clinical research center with extensive expertise in autoimmune disorders and inflammatory conditions. The center has established itself as a prominent site for evaluating novel therapeutic interventions across a diverse range of immune-mediated diseases, with particular emphasis on rheumatologic, dermatologic, and gastroenterologic conditions.
- Psoriatic arthritis and related spondyloarthropathies, including axial manifestations
- Systemic lupus erythematosus and Sjögren's syndrome autoimmune disorders
- Inflammatory bowel diseases including Crohn's disease and ulcerative colitis
- Chronic pain conditions including osteoarthritis, neuropathic pain, and chronic low back pain
The facility conducts comprehensive Phase 2 and Phase 3 clinical trials investigating both biologic and small molecule therapies. Research activities encompass rheumatoid arthritis, plaque psoriasis, chronic urticaria, prurigo nodularis, and thyroid eye disease. Additionally, the center maintains active programs in respiratory medicine, including asthma research, and metabolic conditions such as hyperuricemia associated with gout. The center's multidisciplinary approach enables evaluation of novel immunomodulatory agents across multiple therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 11 therapeutic areas and 15 of 58 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 56 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 12 by active trials.
lock +11 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +11 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinica Gaias Santiago
lock Showing 1 of 57 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| 22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis | Acelyrin Inc. | Phase IV | Not Recruiting | Apr 2023 | Oct 2024 |
IMP list
lock Showing 1 of 58 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.